USPTO 2015–2025 USPTO PatentsView US Corporation

Twist Bioscience Corporation

USPTO PatentsView assignee record - 65 granted patents across 21 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

RSS updates for this company

The verdict

According to USPTO PatentsView, Twist ranks #5,334 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 21 technology areas.

#5,334
of 49,997 US assignees by volume
Top 16%
by Innovation Score (48.8/100)
17.0
avg claims per patent
+200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5334 · US Corporation #5,334 · 65 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 65 grants
  • UPPER-Q #5,334/49,997
  • PHOTO-FINISH Theragun
  • CPC-FOCUS C12N · 21 areas
  • INNOV-PAR 48.8/100
  • CLAIMS-RICH 17.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +200% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Theragun, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Twist

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Twist's Innovation Score is 48.8/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Twist's grants concentrate

Twist Bioscience Corporation is a focused PatentsView assignee: 21 CPC subclasses with 70.8% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (10 grants) versus a trough of 2 in 2016. By volume, Twist sits between Theragun, Inc. and Vayyar Imaging Ltd..

Twist's three-year grant acceleration

From 2019–2021 to 2022–2024, Twist Bioscience Corporation moved from 21 to 25 grants (1.19x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Twist's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Twist holds 65 patents at rank #5,332, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Twist

By rank, the assignees closest to #5,332 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Twist's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Twist, neither rank-band nor same-CPC leaders (those blocks stay above).

Twist's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 2016201720182019202020212022202320242025 9
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Twist Bioscience Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 3.1%
2017 4 6.2%
2018 4 6.2%
2019 4 6.2%
2020 10 15.4%
2021 7 10.8%
2022 10 15.4%
2023 8 12.3%
2024 7 10.8%
2025partial year 9 13.8%

Which technologies does Twist Bioscience Corporation patent most?

Top 15 of 21 technology areas

Where it ranks

Overall rank by patents

#5,334

of 49,997 tracked assignees

Innovation Score

48.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Twist Bioscience Corporation's patent record in context - here's where to go next.

  • Twist Bioscience Corporation's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 70.8% of its portfolio - see every assignee active in that class. Explore C12N
  • Ranked #5,334 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Twist Bioscience Corporation against Theragun, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 48.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.